title: Development of a method for intraparenchymal infusions of 192 IgG-saporin: a comment on Pizzo et al. (1999)
authors.forename: M
authors.initials: M
authors.lastname: Sarter
authors.forename: J P
authors.initials: JP
authors.lastname: Bruno
authors.forename: L A
authors.initials: LA
authors.lastname: Miner
authors.forename: J
authors.initials: J
authors.lastname: McGaughy
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000633:toxicity; D018678:Cholinergic Agents / Q000008:administration & dosage / Q000633:toxicity; D000922:Immunotoxins / Q000008:administration & dosage* / Q000633:toxicity; D007263:Infusions, Parenteral / Q000379:methods; D009699:N-Glycosyl Hydrolases; D009474:Neurons / Q000187:drug effects; D016548:Prosencephalon / Q000187:drug effects / Q000473:pathology*; D051381:Rats; D054789:Ribosome Inactivating Proteins, Type 1; D000076985:Saporins
chemical_list: C085696:192 IgG-saporin; D000911:Antibodies, Monoclonal; D018678:Cholinergic Agents; D000922:Immunotoxins; D054789:Ribosome Inactivating Proteins, Type 1; D009699:N-Glycosyl Hydrolases; D000076985:Saporins